[go: up one dir, main page]

HK1012339A1 - 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives - Google Patents

2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives

Info

Publication number
HK1012339A1
HK1012339A1 HK98113443A HK98113443A HK1012339A1 HK 1012339 A1 HK1012339 A1 HK 1012339A1 HK 98113443 A HK98113443 A HK 98113443A HK 98113443 A HK98113443 A HK 98113443A HK 1012339 A1 HK1012339 A1 HK 1012339A1
Authority
HK
Hong Kong
Prior art keywords
purin
dihydro
oxo
methoxy
amino
Prior art date
Application number
HK98113443A
Other languages
English (en)
Inventor
John J Nestor
Scott W Womble
Hans Maag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1012339(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1012339A1 publication Critical patent/HK1012339A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
HK98113443A 1994-07-28 1998-12-15 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives HK1012339A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28189394A 1994-07-28 1994-07-28

Publications (1)

Publication Number Publication Date
HK1012339A1 true HK1012339A1 (en) 1999-07-30

Family

ID=23079211

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113443A HK1012339A1 (en) 1994-07-28 1998-12-15 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives

Country Status (33)

Country Link
EP (1) EP0694547B1 (de)
JP (1) JP3090305B2 (de)
KR (1) KR100358626B1 (de)
CN (1) CN1045089C (de)
AT (1) ATE179173T1 (de)
AU (1) AU697107B2 (de)
BR (1) BR9503468A (de)
CA (1) CA2154721C (de)
CO (1) CO4410181A1 (de)
CY (2) CY2180B1 (de)
CZ (1) CZ290511B6 (de)
DE (3) DE69509173T2 (de)
DK (1) DK0694547T3 (de)
ES (1) ES2083348T3 (de)
FI (1) FI112080B (de)
GR (2) GR960300021T1 (de)
HK (1) HK1012339A1 (de)
HU (1) HU216867B (de)
IL (1) IL114735A (de)
LU (1) LU91136I2 (de)
MA (1) MA23631A1 (de)
MY (1) MY114393A (de)
NL (1) NL300071I2 (de)
NO (2) NO312899B1 (de)
NZ (1) NZ272652A (de)
PE (1) PE32296A1 (de)
PL (1) PL180609B1 (de)
RU (1) RU2133749C1 (de)
SA (1) SA95160158B1 (de)
TR (1) TR199500895A2 (de)
TW (1) TW434242B (de)
UY (1) UY24006A1 (de)
ZA (1) ZA956228B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
AU1543797A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
AU1592897A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
ES2186127T3 (es) * 1997-02-10 2003-05-01 Medivir Ab Sintesis de derivados de nucleosidos aciclicos.
CN1130362C (zh) * 1997-08-15 2003-12-10 美迪维尔公司 核苷类似物,这些化合物作为包括乙型肝炎病毒(hbv)的逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药
WO1999032490A1 (en) * 1997-12-19 1999-07-01 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
DE60313769T2 (de) * 2002-04-23 2008-03-06 Aventis Pharmaceuticals Inc. 3-(pyridinyl-amino)-1h-indol-2-carbonsäure-verbindungen als inhibitoren der interleukin-4 genexpression
ES2534713T3 (es) 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
ATE398455T1 (de) 2003-01-14 2008-07-15 Gilead Sciences Inc Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
EP1660499A1 (de) * 2003-08-28 2006-05-31 Ranbaxy Laboratories Limited Amorphes valganciclovir hydrochlorid
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド Ppi多回剤形
CN101027318B (zh) * 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物,制剂及其用途
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
KR20100116165A (ko) 2007-10-12 2010-10-29 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 음식 섭취와 관계없이 위장 장애를 치료하는 방법
CN103562207B (zh) * 2011-05-31 2016-08-17 法尔玛赞公司 用于制备缬更昔洛韦的2-氨基-9-((2-苯基-1,3-二噁烷-5-基氧基)甲基)-1h-嘌呤-6(9h)-酮化合物的制备方法
KR102312533B1 (ko) 2021-02-24 2021-10-15 주식회사 이웅 자동 스패너

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
EP0187297B1 (de) * 1984-12-12 1991-08-21 Syntex (U.S.A.) Inc. Derivate von Alcoxymethyläther und Alcoxymethylester
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
EP0375329B1 (de) * 1988-12-19 1995-05-31 The Wellcome Foundation Limited Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
IL114735A0 (en) 1995-11-27
CA2154721A1 (en) 1996-01-29
DE694547T1 (de) 1996-10-24
DE69509173D1 (de) 1999-05-27
EP0694547B1 (de) 1999-04-21
CY2004003I1 (el) 2009-11-04
NL300071I2 (nl) 2002-03-01
HU9502238D0 (en) 1995-09-28
HU216867B (hu) 1999-09-28
RU95113148A (ru) 1997-06-27
ES2083348T1 (es) 1996-04-16
NO312899B1 (no) 2002-07-15
CY2180B1 (en) 2002-08-23
TR199500895A2 (tr) 1996-06-21
PL309812A1 (en) 1996-02-05
DE10299032I2 (de) 2006-06-14
AU697107B2 (en) 1998-09-24
DE69509173T2 (de) 1999-10-21
PE32296A1 (es) 1996-08-07
CO4410181A1 (es) 1997-01-09
FI112080B (fi) 2003-10-31
SA95160158B1 (ar) 2006-05-20
MY114393A (en) 2002-10-31
LU91136I2 (fr) 2005-07-06
JP3090305B2 (ja) 2000-09-18
CY2004003I2 (el) 2009-11-04
PL180609B1 (pl) 2001-03-30
NL300071I1 (nl) 2002-02-01
ATE179173T1 (de) 1999-05-15
GR960300021T1 (en) 1996-04-30
NO2003001I2 (no) 2007-06-11
MA23631A1 (fr) 1996-04-01
JPH0841061A (ja) 1996-02-13
EP0694547A2 (de) 1996-01-31
KR100358626B1 (ko) 2003-01-14
CZ290511B6 (cs) 2002-08-14
AU2719595A (en) 1996-02-08
DE10299032I1 (de) 2003-01-23
CN1122804A (zh) 1996-05-22
EP0694547A3 (de) 1996-06-05
FI953592A0 (fi) 1995-07-27
UY24006A1 (es) 2001-07-31
NZ272652A (en) 1996-12-20
ES2083348T3 (es) 1999-08-01
IL114735A (en) 1998-06-15
DK0694547T3 (da) 2000-01-03
CA2154721C (en) 2001-01-02
HUT73246A (en) 1996-07-29
BR9503468A (pt) 1996-02-27
CN1045089C (zh) 1999-09-15
TW434242B (en) 2001-05-16
NO952977D0 (no) 1995-07-27
GR3030678T3 (en) 1999-11-30
CZ193995A3 (en) 1996-02-14
ZA956228B (en) 1996-02-22
KR960004345A (ko) 1996-02-23
NO952977L (no) 1996-01-29
FI953592L (fi) 1996-01-29
RU2133749C1 (ru) 1999-07-27

Similar Documents

Publication Publication Date Title
HK1012339A1 (en) 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives
AU7820491A (en) Substituted Phthalides and Heterocyclic Phthalides and derivatives thereof.
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
AU8979191A (en) 3,7-disubstituted indole derivatives
CA2011329A1 (en) Xanthine derivatives
CA2244680A1 (en) Process for preparing purine derivatives
ATE172985T1 (de) Sulfonamidaminomethylenderivate als immunsuppressiva
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
FI931794A0 (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
LT2417B (lt) Mo budas vaiku astrios leukozes nepalankios eigos isaiskini
AU8803091A (en) Method for protecting the myocardium against ischemia
FI934920A0 (fi) Gjutstycke, foerfarande foer dess framstaellning och anvaendning av det

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150718